These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 17637184)

  • 1. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome.
    Sun D; Yu LX; Hussain MA; Wall DA; Smith RL; Amidon GL
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):75-85. PubMed ID: 14982151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of different drug transport routes in permeability screening.
    Matsson P; Bergström CA; Nagahara N; Tavelin S; Norinder U; Artursson P
    J Med Chem; 2005 Jan; 48(2):604-13. PubMed ID: 15658873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physiological model for the estimation of the fraction dose absorbed in humans.
    Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
    J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
    Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
    Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling.
    Shono Y; Jantratid E; Janssen N; Kesisoglou F; Mao Y; Vertzoni M; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2009 Sep; 73(1):107-14. PubMed ID: 19465123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating drug permeability with dissolution profile to develop IVIVC.
    Takano R; Kataoka M; Yamashita S
    Biopharm Drug Dispos; 2012 Oct; 33(7):354-65. PubMed ID: 22581486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption.
    Bergström CA
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):156-61. PubMed ID: 15733209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability.
    Akamatsu M; Fujikawa M; Nakao K; Shimizu R
    Chem Biodivers; 2009 Nov; 6(11):1845-66. PubMed ID: 19937826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
    Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
    Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.